Funding for this research was provided by:
Seppo Nieminen fund
Sigrid Juséliuksen Säätiö
F. Hoffmann-La Roche
Received: 20 September 2018
Accepted: 19 July 2019
First Online: 24 July 2019
Ethics approval and consent to participate
: The Ethics Committee of Tampere University Hospital approved the study protocol (R08142M). The trial identifier is NCT00979641. All study patients gave their written informed consent. In addition, the participants in the breast cancer primary prevention study gave their written informed consent for their blood samples to be used for scientific purposes, and this study was also approved by the Ethics Committee of Tampere University Hospital (R15023).
: Not applicable
: The authors declare that they have no competing interests.